Literature DB >> 18702119

Ordering and disordering of molecular solids upon mechanical milling: the case of fananserine.

A De Gusseme1, C Neves, J F Willart, A Rameau, M Descamps.   

Abstract

In this article, we study the physical transformations of the forms III and IV of fananserine upon mechanical milling. The investigations have been performed through X-Ray powder diffraction and differential scanning calorimetry experiments. The results indicate that both forms undergo a polymorphic transformation toward the metastable form I upon milling at room temperature (25 degrees C) while an amorphization is observed upon milling at 0 degrees C. It thus appears that the nature of the transformation induced by milling does not depend on the initial polymorphic state, but strongly depends on the milling temperature. Interestingly, the change in the nature of the transformation with the milling temperature occurs in a short temperature range around the glass transition temperature (T(g) = 19 degrees C). The implication of T(g) in the duality "amorphisation/polymorphic transformation" generally observed upon milling is thus discussed. The physical stability of the end products is also investigated and discussed with respect to the storage temperature of the material.

Mesh:

Substances:

Year:  2008        PMID: 18702119     DOI: 10.1002/jps.21472

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  Preparation and characterization of co-grinded mixtures of aceclofenac and neusilin US2 for dissolution enhancement of aceclofenac.

Authors:  Ambarish H Vadher; Jolly R Parikh; Rajesh H Parikh; Ajay B Solanki
Journal:  AAPS PharmSciTech       Date:  2009-05-15       Impact factor: 3.246

2.  Understanding Concomitant Physical and Chemical Transformations of Simvastatin During Dry Ball Milling.

Authors:  Dattatray Modhave; Isha Saraf; Anjali Karn; Amrit Paudel
Journal:  AAPS PharmSciTech       Date:  2020-05-21       Impact factor: 3.246

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.